Massachusetts Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-126,849
| Closed | -$256K | – | 903 |
|
|
2022
Q1 | $256K | Buy |
126,849
+1,302
| +1% | +$2.63K | ﹤0.01% | 851 |
|
|
2021
Q4 | $340K | Sell |
125,547
-2,541
| -2% | -$6.88K | ﹤0.01% | 870 |
|
|
2021
Q3 | $571K | Sell |
128,088
-1,681
| -1% | -$7.49K | ﹤0.01% | 867 |
|
|
2021
Q2 | $753K | Buy |
129,769
+1,113
| +0.9% | +$6.46K | ﹤0.01% | 861 |
|
|
2021
Q1 | $903K | Sell |
128,656
-15,247
| -11% | -$107K | ﹤0.01% | 843 |
|
|
2020
Q4 | $691K | Sell |
143,903
-1,444
| -1% | -$6.93K | ﹤0.01% | 822 |
|
|
2020
Q3 | $847K | Buy |
+145,347
| New | +$847K | ﹤0.01% | 790 |
|